Metformin and thiazolidinedione use in Medicare patients with heart failure

Article Abstract:

About one-fourth of all patients with both diabetes and heart failure are taking a diabetes drug that should not be given to these patients, according to a study of 12,505 patients surveyed in 1998-1999 and 13,158 surveyed in 2000-2001. Twenty-four percent received a prescription for metformin or a thiazolidinedione drug even though the FDA warns against giving these two drugs to patients with both diabetes and heart failure. In medical terms, these two drugs are contraindicated in patients with both diabetes and heart failure.

Drug therapy, Diabetes, Diabetes mellitus, Metformin, Thiazolidinediones

---

Racial and ethic differences in time to acute reperfusion therapy for patients hospitalized with myocardial infarction

Article Abstract:

Race and ethnicity differences in door-to-drug and door-to-balloon times for patients receiving primary reperfusion for ST-segment elevation myocardial infarction are estimated. The results revealed that a substantial portion of the racial and ethnic disparity in time to treatment was accounted for by the specific hospital to which patients were admitted, in contrast to differential treatment by race and ethnicity inside the hospital.

Science & research, Public affairs, Ethics, Social aspects, Research, Ethical aspects, Cardiac patients, Reperfusion (Physiology)

---

Race, quality of care, and outcomes of elderly patients hospitalized with heart failure

Article Abstract:

Elderly African-Americans who have heart failure receive the same quality of care that white patients do, according to a study of 29,732 Medicare patients. The African-American patients were hospitalized more frequently but had lower death rates than the white patients. African-Americans are more likely to develop heart failure than whites.

United States, Health aspects, Care and treatment, Aged, Elderly, Patient outcomes, Mortality, Demographic aspects, African Americans

Similar abstracts:

• Abstracts: Effects of vesnarinone on morbidity and mortality of patients with heart failure. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure
• Abstracts: The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Eplerenone, a selective aldosterone blocker, in patinets with left ventricular dysfunction after myocardial infarction
• Abstracts: How can the NHS function safely if nurse numbers are cut? Rear view. We need mavericks to save the NHS
• Abstracts: The impact of the new. A review of training is long overdue in mental health nursing
• Abstracts: Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.